Brief: Cohance Lifesciences Says U.S. FDA Issues Form 483 With Five Observations For Jaggaiahpet Unit In Andhra Pradesh
21/09/2026 07:17
BRIEF-Cohance Lifesciences Says U.S. FDA Issues Form 483 With Five Observations For Jaggaiahpet Unit In Andhra Pradesh Sept 21 (Reuters) - Cohance Lifesciences Ltd COHA.NS:
U.S. FDA ISSUES FORM 483 WITH FIVE OBSERVATIONS FOR JAGGAIAHPET UNIT IN ANDHRA PRADESH
Further company coverage: COHA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cohance Lifesciences
See all newsBrief: Cohance Lifesciences Names Abhimanyu Ojha As CFO
Brief: Cohance Lifesciences Says U.S. FDA Issues Form 483 With Five Observations For Jaggaiahpet Unit In Andhra Pradesh
India's Cohance Lifesciences falls after US FDA inspection at Telangana plant
Brief: Cohance Lifesciences Says Investment Of USD 18 Million In NJ Bio And Aruka Bio
India's Cohance Lifesciences climbs on second-half growth outlook despite Q1 loss